Suoping Zhai

Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia.

Steven D. Gore, Li-Jun Weng, William D. Figg et al. · PubMed · 2002 · 153 citations

Hematological Malignancy, Hdac Inhibition, Oncology +13

Phase I Clinical and Pharmacokinetic Study of Flavopiridol Administered as a Daily 1-Hour Infusion in Patients With Advanced Neoplasms

Antoinette R. Tan, Donna Headlee, Richard A. Messmann et al. · Journal of Clinical Oncology · 2002 · 120 citations

Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids.

Suoping Zhai, Renke Dai, Fred K. Friedman et al. · PubMed · 1998 · 120 citations

Molecular Pharmacology, Medicinal Chemistry, Polyphenolics +14

Phase II Trial of Carboxyamidotriazole in Patients With Relapsed Epithelial Ovarian Cancer

Mahrukh M. Hussain, Herbert L. Kotz, Lori M. Minasian et al. · Journal of Clinical Oncology · 2003 · 88 citations

A Phase I/II Study of Infusional Vinblastine with the P-Glycoprotein Antagonist Valspodar (PSC 833) in Renal Cell Carcinoma

Susan E. Bates, Susan Bakke, Min H. Kang et al. · Clinical Cancer Research · 2004 · 69 citations · Full text